ALK-IN-39
ALK-IN-39 is an ALK inhibitor. ALK-IN-39 targets anaplastic lymphoma kinase fusion proteins and inhibits NPM-ALK-dependent proliferation. ALK-IN-39 inhibits the proliferation of cells expressing Tel-InsR as well as wild-type hematopoietic cells and anaplastic large cell lymphoma cells. ALK-IN-39 can be used in research on anaplastic large cell lymphoma (ALCL).
For research use only. We do not sell to patients.
- CAS No.: 845812-90-0
- Formula: C32H44ClN7O3S
- Molecular Weight:642.25
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 845812-90-0
-
Molecular Weight 642.25
-
Formula C32H44ClN7O3S
-
SMILES
O=S(C1=C(NC2=NC(NC3=CC=C(N4CCC(CC4)N5CCN(CC5)C)C=C3OC(C)C)=NC=C2Cl)C=CC=C1)(C(C)C)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Marsilje TH, et al. Synthesis, structure-activity relationships, and in vivo efficacy of the novel potent and selective anaplastic lymphoma kinase (ALK) inhibitor 5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine (LDK378) currently in phase 1 and phase 2 clinical trials. J Med Chem. 2013 Jul 25;56(14):5675-90. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- ALK-IN-39
- 845812-90-0
- Anaplastic lymphoma kinase (ALK)
- Ba/F3-NPM-ALK
- GSH adduct formation
- Karpas299
- NPM-ALK inhibitor
- NPM-ALK-dependent proliferation
- Tel-InsR-expressing hematopoietic cells
- anaplastic large cell lymphoma
- anaplastic lymphoma kinase fusion protein
- antiproliferative agent
- wild-type hematopoietic cells
- Inhibitor
- inhibitor
- inhibit